Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SALVENT STERULES | 0.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19114 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Resolved | 2017-03-12 | 2017-05-10 | 689 |
| APO-SALVENT-IPRAVENT STERULES | 0.5MG 2.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19323 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2022-02-04 | 2022-07-11 | 154208 |
| APO-SAXAGLIPTIN | 2.5MG | TABLET | Resolved | 2022-01-14 | 2022-07-19 | 152773 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2021-12-10 | 2022-01-31 | 150896 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2024-10-24 | 2025-01-03 | 241063 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-17 | 2024-01-12 | 210683 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-11-28 | 2018-02-23 | 30963 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-05-24 | 2024-07-05 | 228786 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2018-07-16 | 2018-08-31 | 55847 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-04-15 | 2020-05-11 | 112195 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-27 | 2024-04-12 | 223540 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-11-10 | 2024-01-19 | 209945 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2021-10-01 | 2021-12-06 | 146514 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2024-08-09 | 2024-09-06 | 234992 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-11-28 | 2018-01-18 | 30967 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-11-09 | 2018-01-31 | 28709 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-06-13 | 2017-10-12 | 12698 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2018-02-21 | 2018-06-12 | 40377 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
| ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
| ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
| ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
| APO ACETAMINOPHEN TAB 325MG | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |
| APO ACETAMINOPHEN TAB 500MG | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
| APO ACETAMINOPHEN TAB 500MG | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
| APO ACETAMINOPHEN TAB 500MG | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
| APO CARBAMAZEPINE TAB 200MG | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
| APO CHLORPROPAMIDE TAB 250MG | 250 mg | tablet | Discontinued | 2017-03-13 | 2018-02-05 | 1235 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70787 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |